potent and selective SOS1/KRAS inhibitor

related cmpd in Ph. I for KRAS+ cancers

from biochemical HTS and SBDD

Cancer Discovery, Aug. 19, 2020

Boehringer Ingelheim, Vienna, AT

Structure of BI-3406

BI-3406 is a compound which binds to SOS1, preventing it from activating the oncoprotein KRAS. While inhibition of WT-KRAS and MEK alone are anticipated to be toxic, the combination of…


get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: